Funding for this research was provided by:
Eli Lilly and Company
Received: 25 March 2020
Accepted: 18 August 2020
First Online: 7 September 2020
Ethics approval and consent to participate
: All study procedures were in accordance with ethical standards of the 1964 Helsinki Declaration and its later amendments, relevant laws, institutional guidelines, and approved by an institutional review board (Copernicus Group, Cary, NC, US; #COS1–18-173). Participant informed consent (written or verbal) was obtained as approved by the institutional review board.
: Not applicable.
: Laure Delbecque and Theresa Hunter are employees of Eli-Lilly and Company which provided financial support for this study. Jason A. Randall, Aiste Guobyte, Louise Newton, and Tara Symonds are employees of Clinical Outcomes Solutions, who designed and undertook this research.